Tests:CA 125: Difference between revisions

Tests:CA 125
No edit summary
No edit summary
 
(7 intermediate revisions by 4 users not shown)
Line 4: Line 4:


{| class="wikitable"
{| class="wikitable"
! colspan="2" |''Overview''
! colspan="2" |
== Overview ==
|-
|-
|Department
|Department
Line 15: Line 16:
|C125
|C125
C-125
C-125
C12-5
C12-5
|-
|Test Availability
|Tested Monday, Wednesday and Friday afternoons.
Please contact the laboratory if testing is required urgently
|-
|-
|Turnaround Time
|Turnaround Time
Line 21: Line 27:
|-
|-
|Stability – Add test
|Stability – Add test
|
|24 hours
|-
|-
! colspan="2" |
! colspan="2" |
===''Specimen Requirements''===
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen  
|Serum
|Serum
Plasma
|-
|-
|Preferred
|Preferred
|7mL <span style="background:#e30022"> Red-Top </span>,
|<span style="background: #fbec5d"> Yellow-Top</span> SST or <span style="background:#e30022"> Red-Top </span> tube
|-
|-
|Acceptable
|Acceptable
|SST <span style="background: #fbec5d"> Yellow-Top</span>
|
|-
|Unacceptable
|Plasma
|-
|-
|Specimen Transportation
|Specimen Transportation
|
|
|-
|-
|Pediatric Requirements
|Paediatric Requirements
|0.5 <span style="background:#e30022"> Red </span> microtainer  
|0.5 mL <span style="background:#e30022"> Red </span> microtainer  
|-
|-
! colspan="2" |
! colspan="2" |
===''Aliquot Requirements''===
== Aliquot Requirements ==
|-
|Sample
|Serum
|-
|-
|Sample Type
|Preferred Volume
|>500 uL Serum
|>500 uL
|-
|-
|Minimum Volume
|Minimum Volume
|200 uL Serum 
|200 uL
|-
|-
|Aliquot Transportation
|Aliquot Transportation
|Samples should be separated from red cells within 24hrs of collection. 
|Samples should be separated from red cells within 24hrs of collection. 
|-
|-
! colspan="2" |''Clinical Information''
! colspan="2" |
== Clinical Information ==
|-
|-
|Reference Intervals
|Reference Intervals
Line 60: Line 72:
|-
|-
|Test Method
|Test Method
|Abbott Architect analyser using Abbott reagents.    
|Abbott Alinity i series analyser using Abbott reagents.  Chemiluminescent microparticle immunoassay.
 
CMIA method
|-
|-
|Advanced Notice
|Advanced Notice
Line 70: Line 80:
|
|
|-
|-
| colspan="2" |Comments
! colspan="2" |
== Comments ==
|-
|-
| colspan="2" |Tested Tuesdays and Fridays.  Please contact the laboratory if testing required urgently.
| colspan="2" |Used for monitoring Ovarian Carcinoma.
 
Used for monitoring Ovarian Carcinoma.  


For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.
|}
|}
{{DocMeta
| owner = Crossley1
| review_ping =
}}
<!-- review-ping: 2026-09-14T07:57:57.920Z -->